Search clinical trials for: Microbiota-based Formulation RBX7455

Total 40 results

Mayo Clinic
National Cancer Institute (NCI)

Terminated

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
McMaster Children's Hospital
St. Justine's Hospital

Completed

PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (PediCRaFT)

Inflammatory Bowel Diseases | Crohn Disease | Colitis | Pediatric Crohns Disease

Canada
Ochsner Health System
Rebiotix Inc.

Terminated

Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy

Hepatic Encephalopathy | Cirrhosis, Liver

United States
Dr. Ekong E. Udoh

Unknown

Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition

Malnutrition; Moderate

Nigeria
Colorado State University

Completed

Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

Pharmacokinetics | Metabolism | Liver Function

United States
Universidad Europea de Valencia

Not yet recruiting

Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial

Attention Deficit Hyperactivity Disorder
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina; OpenBiome

Withdrawn

Fecal Microbiota Transplantation (FMT) in Treatment of Severe and Enduring Anorexia Nervosa

Anorexia Nervosa

United States
Sanofi

Completed

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Influenza | Myxovirus Infection | Orthomyxoviruses

United States
Hadassah Medical Organization

Completed

The Salivary Microbiome in Children With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

Israel
SCF Pharma
Institut de recherche clinique du littoral (IRCL)

Recruiting

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

Eczema

Canada
Allergan

Completed

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Dry Eye Syndromes

Canada, Australia
Istanbul Medipol University Hospital
Tepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaborators

Recruiting

Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome

Irritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Mixed

Turkey
Gazi University
TC Erciyes University; Enbiosis Biotechnology

Completed

The Effect of AI-based Microbiome Diet on IBS-M Symptoms

Irritable Bowel Syndrome Mixed

Turkey
University of California, Los Angeles

Recruiting

UCLA Breast Cancer Survivor Health Promotion Research Study

Breast Cancer

United States
NewLink Genetics Corporation

Completed

Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers

Healthy

Canada
Children's Hospital of Fudan University

Recruiting

Airway Microbiota Based Treatment of Asthma in Preschool Children (AMBT)

Asthma in Children

China
NYU Langone Health
National Institutes of Health (NIH)

Completed

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer

Oral Cancer

United States
Allergan

Completed

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

Bilateral LASIK Surgery

Australia, Canada
Allergan

Completed

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

Dry Eye Syndrome

United States
Allergan

Completed

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

Dry Eye Syndrome

United States
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
GlaxoSmithKline

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Infections, Papillomavirus

United States, Spain, Finland, Germany, Taiwan, Belgium, Philippines, Canada, Australia, United Kingdom, Thailand, Brazil, Italy, Mexico
University Hospital, Geneva
World Health Organization; AIC Kijabe Hospital

Completed

Study of the Efficacy of Plain Soap and Water Versus Alcohol-based Rubs for Surgical Hand Preparation

Postoperative Wound Infection

Kenya
NewLink Genetics Corporation

Completed

Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers (NLG2111)

Healthy

United States
daphne brockington

Unknown

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD (CARE)

Chronic GVHD After HCT for Cancer or Immune Disease

Canada
Shanghai Zhongshan Hospital

Not yet recruiting

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Non-Small Cell Lung Cancer

China
Queen's University
Hotel Dieu Hospital

Terminated

Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain

Pelvic Pain

Canada
Anne Noonan
National Cancer Institute (NCI)

Recruiting

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma

United States
Domenick Zero
GlaxoSmithKline

Completed

Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model

Caries

United States
National Institute of Allergy and Infectious Diseases...

Completed

Donor Stem Cell Transplantation for Congenital Immunodeficiencies

Inherited Immune Deficiencies

United States
Alcon Research

Completed

AL-15469A for the Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
M.D. Anderson Cancer Center

Active, not recruiting

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Invasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Breast Adenocarcinoma

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Unknown

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Breast Cancer

United States
National University Hospital, Singapore

Unknown

Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study

Acute Lymphoblastic Leukemia (ALL)

Singapore, Malaysia
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Anaplastic Oligoastrocytoma | Oligoastrocytoma | Anaplastic Oligodendroglioma | Mixed Glioma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma

United States
Emory University
National Cancer Institute (NCI)

Withdrawn

Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial

Stage II Intrahepatic Cholangiocarcinoma AJCC v8 | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Resectable Intrahepatic Cholangiocarcinoma | Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 | Stage I Intrahepatic Cholangiocarcinoma AJCC v8

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States

Search clinical trials for: Microbiota-based Formulation RBX7455

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations